Association between age at diagnosis and clinical presentation and outcomes of anca-associated vasculitis. analysis from the dcvas study

Association between age at diagnosis and clinical presentation and outcomes of anca-associated vasculitis. analysis from the dcvas study

Bibliográfalaš dieđut
Váldodahkkit:	Monti, S, Craven, A, Klersy, C, Montecucco, C, Caporali, R, Watts, R, Merkel, PA, Luqmani, R
Materiálatiipa:	Conference item
Almmustuhtton:	BMJ Publishing Group 2018

Geahča maid

Nomenclature and classification of vasculitis - update on the ACR/EULAR diagnosis and classification of vasculitis study (DCVAS).
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2011)

ACR/EULAR-endorsed study to develop Diagnostic and Classification Criteria for Vasculitis (DCVAS).
Dahkki: Craven, A, et al.
Almmustuhtton: (2013)

Cutaneous manifestations of ANCA-associated vasculitis
Dahkki: Chiesafuxench, Z, et al.
Almmustuhtton: (2016)

Prevalence and associations of peripheral neuropathy at disease-onset in ANCA-associated vasculitides: Data from DCVAS study
Dahkki: Michael, C, et al.
Almmustuhtton: (2018)

THU0306 Prevalence and characteristics of neuropathy in patients with ANCA associated vasculitides: data from the DCVAS study
Dahkki: Bischof, A, et al.
Almmustuhtton: (2017)

Global ethnic and geographic idfferences in the clinical features of ANCA-associated vasculitis
Dahkki: Pearce, F, et al.
Almmustuhtton: (2016)

Cutaneous manifestations of ANCA-associated vasculitis are common, varied, and associated with systemic disease
Dahkki: Micheletti, R, et al.
Almmustuhtton: (2017)

Predictors of renal involvement in ANCA associated vasculitis
Dahkki: Kronbichler, A, et al.
Almmustuhtton: (2018)

Diagnosis and management of ANCA associated vasculitis.
Dahkki: Berden, A, et al.
Almmustuhtton: (2012)

Damage assessment in ANCA-associated vasculitis.
Dahkki: Bhamra, K, et al.
Almmustuhtton: (2012)

Outcome measures in ANCA-associated vasculitis.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2010)

Maintenance of clinical remission in ANCA-associated vasculitis.
Dahkki: Luqmani, R
Almmustuhtton: (2013)

Cardiovascular outcomes in ANCA associated vasculitis
Dahkki: Mukhtyar, C, et al.
Almmustuhtton: (2008)

Opinion: Maintenance of clinical remission in ANCA-associated vasculitis
Dahkki: Luqmani, R
Almmustuhtton: (2013)

ANCA Associated Vasculitis Subtypes: Response [Letter]
Dahkki: Merkel PA, et al.
Almmustuhtton: (2022-09-01)

SY4_1 Giant cell arteritis (GCA) and Takayasu arteritis (TAK): a spectrum within the same disease or not? A report from the DCVAS project
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2017)

Global ethnic and geographic differences in the clinical presentations of anti-neutrophil cytoplasm antibody-associated vasculitis
Dahkki: Pearce, F, et al.
Almmustuhtton: (2017)

Comparison of disease activity measures for ANCA-associated vasculitis.
Dahkki: Merkel, P, et al.
Almmustuhtton: (2004)

ANCA-associated vasculitis: Where can we go from here?
Dahkki: Luqmani, R
Almmustuhtton: (2010)

Classification criteria for the anca-associated vasculitides
Dahkki: Robson, J, et al.
Almmustuhtton: (2019)

DEVELOPMENT OF DIAGNOSTIC CRITERIA FOR PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
Dahkki: McLaren, J, et al.
Almmustuhtton: (2003)

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
Dahkki: Lapraik, C, et al.
Almmustuhtton: (2007)

Long-term survival of ANCA-associated vasculitis
Dahkki: Flossmann, O, et al.
Almmustuhtton: (2009)

EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Dahkki: Yates, M, et al.
Almmustuhtton: (2016)

EULAR/ERA-EDTA RECOMMENDATIONS FOR THE MANAGEMENT OF ANCA-ASSOCIATED VASCULITIS
Dahkki: Yates, M, et al.
Almmustuhtton: (2016)

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
Dahkki: Ntatsaki, E, et al.
Almmustuhtton: (2014)

DIAGNOSTIC CRITERIA FOR ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV) IN PATIENTS PRESENTING WITH ACUTE PULMONARY AND/OR RENAL DISEASE
Dahkki: McLaren, J, et al.
Almmustuhtton: (2004)

Explaining fatigue in ANCA-associated vasculitis.
Dahkki: Basu, N, et al.
Almmustuhtton: (2013)

Explaining fatigue in ANCA-associated vasculitis
Dahkki: Basu, N, et al.
Almmustuhtton: (2013)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
Dahkki: Arnold, D, et al.
Almmustuhtton: (2010)

THE DEMOGRAPHY OF ANCA ASSOCIATED VASCULITIS: 735 PATIENTS RECRUITED AT DIAGNOSIS TO SIX EUROPEAN VASCULITIS STUDY GROUP TRIALS
Dahkki: Yew, S, et al.
Almmustuhtton: (2012)

Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis.
Dahkki: Jones, R, et al.
Almmustuhtton: (2010)

The OMERACT core set of outcome measures for use in clinical trials of ANCA-associated vasculitis.
Dahkki: Merkel, P, et al.
Almmustuhtton: (2011)

Epidemiology of ANCA associated vasculitis
Dahkki: Wenche Koldingsnes, et al.
Almmustuhtton: (2008-01-01)

Long-term patient survival in ANCA-associated vasculitis
Dahkki: Flossmann, O, et al.
Almmustuhtton: (2011)

Long-term patient survival in ANCA-associated vasculitis.
Dahkki: Flossmann, O, et al.
Almmustuhtton: (2011)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
Dahkki: Suppiah, R, et al.
Almmustuhtton: (2011)

The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV)
Dahkki: Luqmani, R, et al.
Almmustuhtton: (2017)

Markers for work disability in ANCA-associated vasculitis
Dahkki: Basu, N, et al.
Almmustuhtton: (2013)